Member Info for CrustyPete

I have been out for a couple of hours and returned to see 20.0p on the bid. I have to say that today has been quite a sobering day. 33% off it's peak of only yesterday. And now all of the TA and Charting is negative too, so could see this go lower.

I have to say that I did have some reservations after Phil's audience at the Committee yesterday but nothing to justify a pull back of this degree.....

I have been out for a couple of hours and returned to see 20.0p on the bid. I have to say that today has been quite a sobering day. 33% off it's peak of only yesterday. And now all of the TA and Charting is negative too, so could see this go lower.

I have to say that I did have some reservations after Phil's audience at the Committee yesterday but nothing to justify a pull back of this degree.....

Some half decent buying volumes at last and, no doubt as a consequence, a small tick up. Is this the start of the climb from the recent bottom? I hope so; over mine and my wife's accounts down nearly £120k over just less than 24 hours!

No matter, this was always a longer term play and so it remains - and now with an extra 100,000 shares too!

GLA

Well Henry I haven't sold any on the way down (unfortunately!) but have just taken another bite of the cherry at 22.0p - so naturally I hope your purchase does you well!

Well Henry I haven't sold any on the way down (unfortunately!) but have just taken another bite of the cherry at 22.0p - so naturally I hope your purchase does you well!

It seems I was a little hasty with my purchase! Ha! :0)

I would broadly agree with your summary chester, particularly concerning the Nasdaq listing and MHRA approvals (though, as Phil suggested yesterday, MHRA approval is a secondary consideration after FDA approval and fast track designation). I believe you also pointed out yesterday that even without access to AIM for US "investors" Nasdaq is NOT the only alternative option (JV, partnership etc) but with NASDAQ some months away we are now reliant on a GT deal, milestone payments, or the sale of one or more of our platforms for the capital to advance the iSCIB1+ phase3 trials - OR and this may be anoter contributor to the short term sell-off another AIM fundraise......

FWIW I doubt this will be their chosen solution but, with a number of options and no great clarity, I suspect that some have chosen to take a "risk off" attitude until greater clarity around funding becomes apparent - not least because until we have that funding we know that our Nomad will not be increasing their NAV and target share price; so at high 20's or even 30.0p there is limited upside for the short termers.

I hope so bobbust, as I have just bought a few more (50,000) - you don't get as many for the pound these days!!

Good luck all.

Looks as if those sellers are out in force again this morning.

Those buying upwards of 28.0p yesterday will be feeling the pinch today - down 7.55% at 24.0 - 24.5p. Where have all the buyers gone! :0)

It will turn I'm sure but when? - may be doing some "bottom fishing" myself later on....

That would solve the problem as described by Phil at yesterday's committee but qualifying rules may preclude it (market cap is not the only hurdle), they are often considered unpalatable and, moreover, a full listing is a lot more expensive both to be a member and to abide by the listing rules.

Thanks JennyT but 4D pharma is a memory that I would rather not revisit.....

A flotation on Nasdaq in and of itself will not necessarily affect our AIM listing at all. As many have pointed out a Dual listing is perfectly possible and the most likely scenario, in which case there is nothing to worry about. The issues would only occur if Scancell chose to delist from AIM and there has been no suggestion whatsoever that a delisting is planned.

75.20 - 81.60p...... predictable but disappointing.

Where is that J7 news? Or do the BoD no longer consider it worthy of notification?

Still being used by M&P - as I have said before they wont sign a contract until M&P are a lot closer to finishing their drill programme. A lot can happen between now and the end of the drilling of the third well, with potential delays, repairs, needing spares etc. ARA will want to know exactly what they are inheriting before committing to contract details methinks.

These rules don't appear to have gone down very well with shareholders in Canada - CAN $1.40 or £0.76p. So yes we do need that J7 news asap; though to what extent it will now have the same impact post the new rules is a moot point?

From 2025 AGM, 25th July 25 12.57:

"During the Q&A Robert Ambrose (ARA NED on the Board) clearly stated that a rig share with M&P was very much still on the cards and implied that the Tender gave them greater leverage to negotiate a better deal with M&P / Operator. Furthermore in conversation it was stressed that being "in country" meant that sharing would be cheaper and that alternative out of country options would, likely as not, provide no great timing advantage.

And after the AGM 2024 July 2nd.

Well since now the cat is out of the bag, Ufufuo you say below:

"FINALISING RIG SHARE CONTRACTOR - Aminex cannot currently confirm exact dates as we have identified an opportunity to share a rig with another operator in country that needs to drill some wells. Crucially, according to The Board, this arrangement:

1. Seems very likely to allow us to meet the timelines stated above

2. Will allow us to save considerable costs, preserving more of the free carry

3. Means that we will have use of a rig that is due to be in Tanzania within the next month"

I had the same conversation but with a slightly different conclusion - that the timeline for the the rig discussed was somewhat different to the timeline you suggest in point 3 above.

Where is Mctripe / stockcheque now? Lol!

Quelle surprise...... Well, to some anyway. And yet how many said that would never happen?

"The same drilling rig will subsequently move to the Ntorya area in the Ruvuma Block — also in Mtwara — where TPDC plans to drill one new exploration well, conduct a workover on a previously drilled well, and carry out tests on a third. "

The Spread at 13.37 was 18.50 - 19.0p and yes it may have taking some time to execute that 1.5m but likely to be a sell. But hey, it's history now and the sp closed up 6% - now have post close sales to absorb.

Here's looking for a another positive day. Good luck and goodnight.

Indeed Pepe and Quoth, as it happens I tend to agree with you both.

Anyway, I have to run for a train. Goodnight all.

In SCLP's case their own particular "sell-off" began with the close of Phil's attendance at the Science and Technology Committee. Was there anything there that may have put them off? Perhaps, as I commented earlier, his suggestion (reading between the lines) that SCLP may need to float on Nasdaq to find the funding for their Phase 3 iSCIB1+ trial?

I have noticed that there appears to have been a noticeable sell-off of a large number of UK small cap shares this afternoon (aprticularly AIM), starting with the opening of the US markets at 2:00. Though as yet cannot find any commentary as to why....?